Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07352527 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS

Study acronym: MACSCORE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The recent development of quantitative steroid metabolome profiling could be of interest for the positive diagnosis of mild autonomous cortisol-secreting adenoma (MACS). The aim of the study is to develop a predictive model of MACS status or non-secreting adenoma (NSA) based on a panel of 19 serum steroids and three clinico-biological parameters (body mass index or BMI, fasting glycaemia, blood pressure) and to estimate its performance for the diagnosis of MACS in a cohort of patients followed in the endocrinology department of Bordeaux University Hospital.
Trial Details
NCT Number NCT07352527
Lead Sponsor University Hospital, Bordeaux
Conditions
(from sponsor)		 Endocrine Disease
Related terms Endocrine System Diseases
Enrollment 291 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov